Jan 31, 2025 · The United States Food and Drug Administration (FDA) has licensed three single-antigen vaccines (Engerix-B, Heplisav-B, and Recombivax HB), and three combination vaccines (Pediarix, Vaxelis, and Twinrix) to protect against hepatitis B.

ENGERIX-B is a vaccine indicated for immunization against infection caused by all known subtypes of hepatitis B virus. (1) Severe allergic reaction (e.g., anaphylaxis) after a previous dose of...

Oct 29, 2024 · Engerix-B vaccine is used to help prevent hepatitis B. Hepatitis B is a liver disease that can cause mild illness lasting a few weeks, or it can lead to a serious, lifelong illness. Engerix-B vaccine helps your body develop immunity to the disease, but will not treat an active infection you already have.

Oct 30, 2023 · ENGERIX-B is a vaccine indicated for immunization against infection caused by all known subtypes of hepatitis B virus.

ENGERIX-B (hepatitis B vaccine (recombinant)) is indicated for: active immunization against hepatitis B virus infection. The National Advisory Committee of Immunization (NACI) provides additional guidance on the use of hepatitis B vaccines in Canada. Please refer to the Canadian Immunization Guide. 1.1 Pediatrics

Medscape - Immunization dosing for Engerix B, Heplisav-B (hepatitis B vaccine), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation...

ENGERIX-B [Hepatitis B Vaccine (Recombinant)] is a noninfectious recombinant DNA hepatitis B vaccine developed and manufactured by GlaxoSmithKline Biologicals. It contains purified surface antigen of the virus obtained by culturing genetically engineered Saccharomyces cerevisiae cells, which carry the surface antigen gene of the hepatitis B virus.

Hepatitis B vaccine info for healthcare professionals, including vaccine recommendations, vaccine information, storage and handling, administering vaccine, references and resources.

Nov 27, 2024 · Detailed dosage guidelines and administration information for Engerix B (hepatitis b vaccine (recombinant)). Includes dose adjustments, warnings and precautions.

Engerix-B 10 mcg and Engerix-B 20 mcg are the funded hepatitis B vaccines for: Adults aged 18 years or older who meet 'special groups' eligibility criteria. Engerix-B 20 mcg is also the vaccine available for purchase by adults who are not eligible for funded hepatitis B vaccine but for whom hepatitis B vaccine is recommended.